Fast and continuous synthesis of nanostructured iron spinel in supercritical water: influence of cations and citrates

L. Maurizi , F. Bouyer, M. Ariane, R. Chassagnon and N. Millot*
Laboratoire Interdisciplinaire Carnot de Bourgogne, UMR 6303 CNRS/Université de Bourgogne, 9 avenue Alain Savary, BP 47870, 21078 Dijon cedex, France. E-mail: nmillot@u-bourgogne.fr

Received 12th August 2014 , Accepted 8th September 2014

First published on 10th September 2014


Abstract

Spinel iron oxide nanoparticles were obtained under supercritical water conditions in a continuous and fast (less than 10 s) way by modifying the initial stoichiometric FeII/FeIII molar ratio from (1/2) to (3/0), without base solution, and using citrates directly with iron precursors. This result opens the way to an economical and environmentally benign approach to synthesize superparamagnetic iron oxide nanoparticles (SPIONs) in high yields.


Introduction

Metallic oxide nanoparticles are more and more used as-synthesized for different applications such as catalysis,1,2 pollution treatments, or with biocompatible coatings3–7 for bio-applications such as Magnetic Resonance Imaging (MRI)8–11 or hyperthermia.12–14 Nowadays, adapting their laboratory fabrication to a more industrial production is a huge challenge.15 Hydrothermal syntheses may be an appropriate route to solve this problem either by a batch16–19 or continuous way.20–25 In parallel, a derivative method was developed using the supercritical properties of water. Above critical temperature and pressure values (P > 22 MPa and T > 647 K), the properties of water drastically change.26 The dissociation constant of water is much smaller (roughly 3 times) in supercritical conditions than in normal conditions27,28 leading to a higher dissolution power for organic compounds which is ideal for organic pollutants extraction.29 The small dielectric constant of supercritical water allows synthesis of metallic oxide nanoparticles without any base30–34 and in a very short reaction time.24 However, in the case of iron oxide nanoparticles the hematite phase is usually obtained24,30,35 because of the oxidative properties of supercritical water. The same trend was also observed with hydrothermal conditions. In recent papers, it was shown that anti-oxidative molecules such as ascorbic acid36 or citrates37 prevented the oxidation of iron oxide and stabilized the magnetite (Fe3O4) phase after hydrothermal treatments. In addition, citrates allowed the control of the crystallite growth.37,38

In this paper, iron oxide nanoparticles were synthesized in a continuous supercritical water process without base solution. By tuning the molar ratio FeII/FeIII and by adding citrates to the precursor solution, the iron oxide phase shifted from hematite phase (α-Fe2O3) to exclusive spinel phase (Fe3(1−δ)O4) opening the way of a production of superparamagnetic iron oxide nanoparticles (SPIONs) in supercritical water, in a continuous way and so with important yields.

Material & methods

The hydrothermal continuous process working in supercritical water conditions was described elsewhere.22,30,39,40 In order to investigate the influence of the oxidation degree of iron cations, three different conditions of reaction were set up. First of all, a molar ratio FeII/FeIII (1/2) was prepared by dissolution of sulfate iron precursors in water (8 × 10−3 M/16 × 10−3 M). The second iron cations solution was prepared with only FeII (3/0) at a concentration of 24 × 10−3 M. The last solution was prepared with FeII too (3/0) plus citrates in a molar ratio (1/1) (24 × 10−3 M of FeII/24 × 10−3 M of citrates). All syntheses were realized in the absence of base. The pressure of the system was fixed at 25 MPa.

The supercritical water process (shown in Fig. 1) has three lines which mixed in the reactor at set-up pressure and temperature. The first line was loaded with the reactants (FeII, FeIII and eventually citrates) the second one with water (no basic reaction's initiator) and a third line where water was preheated at 623 K.41 The mixing point in the reactor was set up in supercritical water conditions (P = 25 MPa, T = 673 K). The flow rate was fixed at 30 mL min−1 to lead to a residential time of 8 seconds. At the exit of the reactor, the suspensions were rapidly cooled-down in water bath, filtered in 7 and 2 μm filters, collected and dialyzed for 48 hours against HNO3 10 mM by changing the dialyzed water every 12 hours. Then suspensions were freeze-dried to be characterized by X-ray Diffraction (XRD Siemens D5000, λKβCu = 1.39222 Å) which gives lattice parameters and crystallite's mean size (dXRD) using Halder and Wagner or Williamson and Hall fitting methods;42–44 Transmission Electron Microscopy (TEM: JEOL JEM-2100 LaB6 microscope) leading to TEM diameters (dTEM) obtained by counting around one hundred of particles on TEM pictures and Specific Surface Areas (SSA: Autosorb 1C from Quantachrome) which can lead to a mean diameter (dBET) equal to 6000/(ρ × SSA) where ρ is the density of the particle in g cm−3 and SSA is in m2 g−1.


image file: c4ra08562k-f1.tif
Fig. 1 Scheme of the hydrothermal process working in continuous and in supercritical water conditions (P = 25 MPa and T = 673 K); precursors in brackets when not present; NP: nanoparticles.

Results and discussion

XRD patterns in Fig. 2a firstly show, that the powders obtained following the 3 different conditions are crystalline iron oxide nanoparticles even without using base. With classical a FeII/FeIII ratio (1/2), the final phase was the rhombohedral hematite (α-Fe2O3) which is the most stable iron oxide phase at high temperature.45
image file: c4ra08562k-f2.tif
Fig. 2 (a) XRD patterns (arbitrary units: a.u.) of iron oxide nanoparticles obtained under continuous supercritical water conditions, without addition of base and with different iron and citrates mass ratios. International Centre for Diffraction Data (ICDD) files used were indicated; (b) Zoom section of the splitting of the diffraction peak of spinel particles obtained with only FeII precursor mixed with citrates molecules in a molar ratio (1/1). Blue star: polluting elements coming from the reactor.

With only FeII cations precursors, two phases were observed: hematite and spinel Fe3(1−δ)O4 phase. Following a previous work45 about the comparison of the intensity of the (104) diffraction peak of hematite and the intensity of the (220) magnetite peak, it was possible to estimate the α-Fe2O3 phase proportion. In the case of the synthesis without citrates, 41% of hematite was present. On this X-ray pattern, the peaks observed around 25° (blue star in Fig. 2a) are due to polluting elements coming from the reactor used during this study. When FeII cations were previously mixed with citrates in a molar ratio (1/1), the phase observed is almost exclusively the spinel one with less than 0.5% of hematite. The diffraction peaks of the powder obtained with citrates (Fig. 2b) consist of two phases corresponding to a phase with sharp peaks and a lattice parameter of (8.397 ± 0.001 Å) and a phase with broad peaks and a lattice parameter of (8.350 ± 0.002 Å). It reveals the simultaneous presence of large mean diameter crystallites of magnetite (Fe3O4), stoichiometric spinel, and of smaller crystallites of maghemite (γ-Fe2O3), lacunary spinel.37,46

TEM observations (Fig. 3) of the three powders confirmed the previous observations. With FeII/FeIII molar ratio (1/2), the particles look like hexagonal or spherical hematite nanoparticles (see Fig. 3a) and the TEM size (dTEM = 72 ± 6 nm) reported in Table 1 is close to the size calculated from the XRD patterns (dXRD = 69 ± 1 nm). The insert zoom section in the Fig. 3a, HRTEM image showing (012) planes, proved also the presence of the crystalline hematite phase. The hematite specific surface area (SSA) is around 12 m2 g−1 leading to a mean diameter (dBET) of 94 ± 15 nm within the same range as the TEM and XRD diameter measurements. With FeII only, TEM pictures show nanoparticles around 100 nm, from hematite phase. These hematite particles are surrounded by very small elongated spinel crystalline particles (zoom section Fig. 3b) around 4 to 6 nm. This hypothesis is verified with HRTEM imaging of one of this elongated crystallites showing the (220) plans of spinel iron oxide phase. Furthermore selected area diffractions were done on these particles during TEM imaging and analyses (Fig. SI given in ESI); these analyses also proved the spinel structure of these small particles. No attempt of statistical analysis of the diameter was undertaken because of the large agglomeration of those small particles. This second phase was also observed in XRD (Fig. 2a). However, regarding the XRD pattern, it was too complicated to desummate the contribution of the two iron oxide phases present and then to obtain XRD diameters. Nevertheless the high value of the average specific area of this powder, 157 ± 1 m2 g−1 proves the presence of very small nanoparticles (around 8 nm), here spinel ones, because hematite is the thermodynamically stable iron oxide phase at high temperature for grain sizes larger than 20 nm.47 With FeII and citrates in a (1/1) molar ratio, the particles observed in TEM are poly-dispersed from few nanometers to half a micron (Fig. 3c). Moreover, the fit of the assymetric diffraction peaks (Fig. 2a, b and Table 1), suggest the presence of two populations of nanoparticles: maghemite nanoparticles of 32 ± 6 nm and magnetite nanoparticles of 106 ± 19 nm. Finally, the average surface area of this powder around 7 ± 1 m2 g−1 proved the presence of bigger particles, than that fitted by XRD, with an average diameter around 170 nm, which is confirmed by TEM observations (Fig. 3c). For the particles synthesized from FeII only with or without citrates, no mean TEM diameter (dTEM) was calculated because of the difficulty to correctly distinguish boundaries and/or quantify very small crystallites.


image file: c4ra08562k-f3.tif
Fig. 3 TEM pictures (with zoom section on top) and TEM diameters distributions of iron oxide nanoparticles synthesized under continuous supercritical water conditions with (FeII/FeIII) molar ratio: (a) (1/2); (b) (3/0); (c) (3/0) + citrates (molar ratio citrates/Fe = 1/1).
Table 1 Physicochemical properties of iron oxide nanoparticles obtained under continuous supercritical conditions for different iron and citrates mass ratiosa
FeII/FeIII molar ratio Citrates/Fe molar ratio Hematite (mass %) α-Fe2O3 dXRD (nm) Fe3(1−δ)O4 dXRD (nm) dTEM (nm) SSA (m2 g−1)
a np: not present; nd: not determined; dXRD: mean diameter measured from XRD patterns; dTEM: mean diameter measured from TEM pictures; SSA: specific surface area.
1/2 0/1 100% 69 ± 1 np 72 ± 6 12 ± 2
3/0 0/1 41% nd nd nd 157 ± 2
3/0 1/1 < 0.5% np 32 ± 6 & 106 ± 19 nd 7 ± 1


In the light of the above results, it is possible to propose a synthesis mechanism of iron oxide nanoparticles from iron precursors in supercritical water. The formation of relatively monodispersed hematite nanoparticles with usual stoichiometric molar ratio FeII/FeIII (1/2) can be explained by the quasi instantaneously oxidation of FeII to FeIII at high temperature and pressure (T = 673 K, P = 25 MPa). Even in classical hydrothermal route, using only FeIII cations in aqueous media usually leads to the formation of α-Fe2O3.48,49 In fact, hematite phase is commonly obtained in supercritical water conditions24,30,35,50 using FeIII precursors. Moreover, as previously said, hematite phase is the thermodynamically stable iron oxide phase at high temperature and when the grains are larger than 20 nm.47 It can also be obtained by heat treatment of iron hydroxides51 or spinel particles.43

To limit the oxidation of FeII and to stabilize the spinel phase, only FeII precursors were used with or without citrates addition. In these cases, two phases of iron oxide nanoparticles were obtained. Without citrates, a mixture of spinel particles (59% mass proportion) and hematite particles (41% mass proportion) were synthesized. Then, with citrates, an exclusive spinel phase (hematite mass ratio < 0.5%) was obtained with two types of particles: small maghemite particles (around 30 nm in diameter) and bigger magnetite particles (around 100 nm in average but with some at hundreds of nm to half microns).

The mix of metallic precursors with organic chelates15,52–54 is the usual method described in literature to synthesize spinel particles in supercritical water. In our study, Fe3(1−δ)O4 particles were obtained using FeII precursor previously mixed with citrates. It was demonstrated by Takami et al.55 and in a previous work of our group37 that antioxidant and chelatant properties of citrates avoid formation of α-Fe2O3 and crystallite's growth during hydrothermal syntheses (bellow the critical point). Thanks to this new study, we can attest that it is also the case in supercritical water. This method is faster, cheaper and more environmental friendly than classical organic chelates syntheses.

Regarding the two biphasic distributions obtained with FeII precursors (with or without citrates), one of the hypotheses could be the formation of a sub-stoichiometric molar ratio of FeII/FeIII leading to the formation of spinel structured iron oxide particles. A study of Tronc et al.56 demonstrated that with sub-stoichiometric iron cations molar ratio, it was possible to obtain spinel structured particles. When MetalII/FeIII > 0.2, they obtained metallic hydroxide leading to spinel structured particles. We also observed spinel iron oxide confirming this hypothesis of sub-stoichiometric FeII/FeIII molar ratio. Moreover no goethite phase (α-FeOOH), which should appear when FeII/FeIII < 0.1, was observed. Jolivet et al.57 also explained that in sub-stoichiometric FeII/FeIII molar ratio conditions (1/6) and 24 hours after Ostwald ripening at ambient conditions, two types of particles were synthesized: small particles (few nm) of maghemite and large particles (100 to 150 nm) of magnetite. The big particles grew from a dissolution–reprecipitation process at a quasi-stoichiometric ratio when the small particles are poor in FeII and are formed by FeII adsorption on ferric hydroxide. The stoichiometry of the FeII seems to be crucial in the formation of spinel structured nanoparticles formation in classical aqueous route. Under supercritical water conditions, the same observations were done but with very short reaction time (8 s). When the FeII cations entered the reactor, many of them should be oxidized in FeIII to give a sub-stoichiometric molar ratio (FeII/FeIII) leading to the formation of spinel structured Fe3(1−δ)O4 close to maghemite. Under supercritical water conditions, the Ostwald ripening was accelerated and led to the formation of two populations of spinel particles: small maghemite particles and large magnetite particles. Then, because maghemite particles are already at their maximal oxidized state and certainly because of their small size, they did not turn into other phase. However, the big magnetite particles either oxidized to hematite without citrates or continue to grow larger preventing from oxidizing by citrates molecules as already observed in hydrothermal continuous conditions bellow supercritical point.37 Moreover, adding citrates should have prevented the oxidation of FeII precursors and increased the sub-stoichiometric FeII/FeIII ratio compared to without citrates. This could also explain the absence of hematite phase and the presence of bigger magnetite particles. A summarizing mechanism of the synthesis of spinel structured particles under supercritical water conditions is given in Fig. 4. It was shown that citrates ions played a role in the phase transformation of iron oxide nanoparticles but certainly because of the high temperatures conditions of supercritical water, part of these ions should have been degraded. It certainly decreased the quantity of citrates in the system and did not permit to stabilize the nanoparticles or to decrease either their mean diameter or polydispersity as already observed in hydrothermal continuous synthesis37 below the supercritical field. No real evidence of the citrates coating of the spinel structured iron oxide nanoparticles was found with FTIR, Zeta potential measurements and XPS analyses (Fig. S2 in ESI).


image file: c4ra08562k-f4.tif
Fig. 4 Summary of the synthesis mechanism proposed for the synthesis of iron oxide nanoparticles under continuous supercritical water conditions for different iron and citrates precursor's ratios; SC H2O: supercritical water; ε < 0.5.

Conclusions

First of all, it was possible to obtain in this work, iron oxide nanoparticles using a continuous hydrothermal water synthesis process working under supercritical water conditions without using any base solution and in a very short reaction time (8 s). By changing the initial FeII/FeIII stoichiometric molar ratio from (1/2) to (3/0), the particles structure changed from hematite only to a mixture of spinel and hematite phases. Then by adding citrates ions to FeII precursors in a molar ratio of (1/1), the phases obtained were exclusively spinel structures with small maghemite (γ-Fe2O3) particles and sub-micronic magnetite (Fe3O4) particles. The citrates prevent the oxidation FeII to FeIII even in the supercritical field. Increasing the initial molar ratio of citrates/iron may allow (or lead to) the stabilization of smaller and monodisperse magnetite nanoparticles in a continuous supercritical water process.

Acknowledgements

We gratefully thank both CNRS (Centre National de la Recherche Scientifique) and Conseil Regional de Bourgogne for financial support.

Notes and references

  1. D. L. Huber, Small, 2005, 1, 482–501 CrossRef CAS PubMed.
  2. G. P. Van der Laan and A. Beenackers, Catal. Rev.: Sci. Eng., 1999, 41, 255–318 CAS.
  3. B. Basly, D. Felder-Flesch, P. Perriat, C. Billotey, J. Taleb, G. Pourroy and S. Begin-Colin, Chem. Commun., 2010, 46, 985–987 RSC.
  4. L. Maurizi, H. Bisht, F. Bouyer and N. Millot, Langmuir, 2009, 25, 8857–8859 CrossRef CAS PubMed.
  5. M. Chastellain, A. Petri and H. Hofmann, J. Colloid Interface Sci., 2004, 278, 353–360 CrossRef CAS PubMed.
  6. A. Jordan, R. Scholz, P. Wust, H. Schirra, T. Schiestel, H. Schmidt and R. Felix, J. Magn. Magn. Mater., 1999, 194, 185–196 CrossRef CAS.
  7. L. Maurizi, U. Sakulkhu, L. A. Crowe, V. M. Dao, N. Leclaire, J.-P. Vallée and H. Hofmann, RSC Adv., 2014, 4, 11142–11146 RSC.
  8. A.-L. Papa, L. Maurizi, D. Vandroux, P. Walker and N. Millot, J. Phys. Chem. C, 2011, 115, 19012–19017 CAS.
  9. R. Azoulay, P. Olivier, O. Baud, C. Verney, R. Santus, P. Robert, P. Gressens and G. Sebag, J. Magn. Reson. Imag., 2008, 28, 1046–1052 CrossRef PubMed.
  10. K. Nwe, L. H. Bryant and M. W. Brechbiel, Bioconjugate Chem., 2010, 21, 1014–1017 CrossRef CAS PubMed.
  11. L. Maurizi, A.-L. Papa, L. Dumont, F. Bouyer, P. Walker, D. Vandroux and N. Millot, J. Biomed. Nanotechnol., 2015, 11, 126–136 CrossRef PubMed.
  12. A. Ito, M. Shinkai, H. Honda and T. Kobayashi, J. Biosci. Bioeng., 2005, 100, 1–11 CrossRef CAS PubMed.
  13. M. Chastellain, A. Petri, A. Gupta, K. v. Rao and H. Hofmann, Adv. Eng. Mater., 2004, 6, 235–241 CrossRef CAS.
  14. J. H. Park, K. H. Im, S. H. Lee, D. H. Kim, D. Y. Lee, Y. K. Lee, K. M. Kim and K. N. Kim, J. Magn. Magn. Mater., 2005, 293, 328–333 CrossRef CAS PubMed.
  15. G. R. Patzke, Y. Zhou, R. Kontic and F. Conrad, Angew. Chem., Int. Ed., 2011, 50, 826–859 CrossRef CAS PubMed.
  16. H. Hayashi and K. Torii, J. Mater. Chem., 2002, 12, 3671–3676 RSC.
  17. S. Gyergyek, M. Drofenik and D. Makovec, Mater. Chem. Phys., 2012, 133, 515–522 CrossRef CAS PubMed.
  18. T. J. Daou, G. Pourroy, S. Begin-Colin, J. M. Greneche, C. Ulhaq-Bouillet, P. Legare, P. Bernhardt, C. Leuvrey and G. Rogez, Chem. Mater., 2006, 18, 4399–4404 CrossRef CAS.
  19. J. Wang, J. Sun, Q. Sun and Q. Chen, Mater. Res. Bull., 2003, 38, 1113–1118 CrossRef CAS.
  20. N. Millot, S. Le Gallet, D. Aymes, F. Bernard and Y. Grin, J. Eur. Ceram. Soc., 2007, 27, 921–926 CrossRef CAS PubMed.
  21. S.-A. Hong, S. J. Kim, K. Y. Chung, Y.-W. Lee, J. Kim and B.-I. Sang, Chem. Eng. J., 2013, 229, 313–323 CrossRef CAS PubMed.
  22. N. Millot, B. Xin, C. Pighini and D. Aymes, J. Eur. Ceram. Soc., 2005, 25, 2013–2016 CrossRef CAS PubMed.
  23. K. Sue, K. Murata, K. Kimura and K. Arai, Green Chem., 2003, 5, 659–662 RSC.
  24. T. Adschiri, K. Kanazawa and K. Arai, J. Am. Ceram. Soc., 1992, 75, 1019–1022 CrossRef CAS PubMed.
  25. A. Aimable, B. Xin, N. Millot and D. Aymes, J. Solid State Chem., 2008, 181, 183–189 CrossRef CAS PubMed.
  26. H. Weingartner and E. U. Franck, Angew. Chem., Int. Ed., 2005, 44, 2672–2692 CrossRef PubMed.
  27. P. E. Savage, Chem. Rev., 1999, 99, 603–621 CrossRef CAS PubMed.
  28. C. A. Eckert, B. L. Knutson and P. G. Debenedetti, Nature, 1996, 383, 313–318 CrossRef CAS.
  29. S. B. Hawthorne, Y. Yang and D. J. Miller, Anal. Chem., 1994, 66, 2912–2920 CrossRef CAS.
  30. A. Aimable, H. Muhr, C. Gentric, F. Bernard, F. Le Cras and D. Aymes, Powder Technol., 2009, 190, 99–106 CrossRef CAS PubMed.
  31. R. B. Yahya, H. Hayashi, T. Nagase, T. Ebina, Y. Onodera and N. Saitoh, Chem. Mater., 2001, 13, 842–847 CrossRef CAS.
  32. T. Arita, H. Hitaka, K. Minami, T. Naka and T. Adschiri, J. Supercrit. Fluids, 2011, 57, 183–189 CrossRef CAS PubMed.
  33. J. Lee and A. S. Teja, Mater. Lett., 2006, 60, 2105–2109 CrossRef CAS PubMed.
  34. C. Pighini, D. Aymes, N. Millot and L. Saviot, J. Nanopart. Res., 2007, 9, 309–315 CrossRef CAS.
  35. K. Sue, M. Suzuki, K. Arai, T. Ohashi, H. Ura, K. Matsui, Y. Hakuta, H. Hayashi, M. Watanabe and T. Hiaki, Green Chem., 2006, 8, 634–638 RSC.
  36. K. Sue, H. Hattori, T. Sato, T. Komoriya, A. Kawai-Nakamura, S. Tanaka, T. Hiaki, S. Kawasaki, Y. Takebayashi, S. Yoda and T. Furuya, Chem. Lett., 2009, 38, 792–793 CrossRef CAS.
  37. L. Maurizi, F. Bouyer, J. Paris, F. Demoisson, L. Saviot and N. Millot, Chem. Commun., 2011, 47, 11706–11708 RSC.
  38. A. Bee, R. Massart and S. Neveu, J. Magn. Magn. Mater., 1995, 149, 6–9 CrossRef CAS.
  39. D. Aymes, M. Ariane, F. Bernard, H. Muhr and F. Demoisson, WO2011010056 A1, 2011.
  40. D. B. Murray, C. H. Netting, L. Saviot, C. Pighini, N. Millot, D. Aymes and H.-L. Liu, J. Nanoelectron. Optoelectron., 2006, 1, 92–98 CrossRef PubMed.
  41. F. Demoisson, M. Ariane, R. Piolet and F. Bernard, Adv. Eng. Mater., 2011, 13, 487–493 CrossRef CAS.
  42. T. Belin, N. Millot, F. Villieras, O. Bertrand and J. P. Bellat, J. Phys. Chem. B, 2004, 108, 5333–5340 CrossRef CAS.
  43. N. Millot, D. Aymes, F. Bernard, J. C. Niepce, A. Traverse, F. Bourée, B. L. Cheng and P. Perriat, J. Phys. Chem. B, 2003, 107, 5740–5750 CrossRef CAS.
  44. N. C. Halder and C. N. J. Wagner, in Advances in X-Ray Analysis, ed. G. R. Mallett, M. J. Fay and W. M. Mueller, Springer, US, 1966, pp. 91–102 Search PubMed.
  45. T. Belin, N. Millot, N. Bovet and M. Gailhanou, J. Solid State Chem., 2007, 180, 2377–2385 CrossRef CAS PubMed.
  46. P. Poix, Semin. Chim. Etat Solide, 1966, 1, 1966–1967 Search PubMed.
  47. J.-P. Jolivet, C. Chaneac and E. Tronc, Chem. Commun., 2004, 481–487 RSC.
  48. T. P. Raming, A. J. A. Winnubst, C. M. van Kats and A. P. Philipse, J. Colloid Interface Sci., 2002, 249, 346–350 CrossRef CAS PubMed.
  49. M. Iwasaki, M. Hara and S. Ito, J. Mater. Sci., 2000, 35, 943–949 CrossRef CAS.
  50. C. B. Xu and A. S. Teja, J. Supercrit. Fluids, 2006, 39, 135–141 CrossRef CAS PubMed.
  51. X. H. Liu, G. Z. Qiu, A. G. Yan, Z. Wang and X. G. Li, J. Alloys Compd., 2007, 433, 216–220 CrossRef CAS PubMed.
  52. A. Cabanas and M. Poliakoff, J. Mater. Chem., 2001, 11, 1408–1416 RSC.
  53. K. C. Park, F. Wang, S. Morimoto, M. Fujishige, A. Morisako, X. X. Liu, Y. J. Kim, Y. C. Jung, I. Y. Jang and M. Endo, Mater. Res. Bull., 2009, 44, 1443–1450 CrossRef CAS PubMed.
  54. M. D. de Tercero, M. Bruns, I. G. Martínez, M. Türk, U. Fehrenbacher, S. Jennewein and L. Barner, Part. Part. Syst. Charact., 2013, 30, 229–234 CrossRef.
  55. S. Takami, T. Sato, T. Mousavand, S. Ohara, M. Umetsu and T. Adschiri, Mater. Lett., 2007, 61, 4769–4772 CrossRef CAS PubMed.
  56. E. Tronc, P. Belleville, J. P. Jolivet and J. Livage, Langmuir, 1992, 8, 313–319 CrossRef CAS.
  57. J. P. Jolivet, P. Belleville, E. Tronc and J. Livage, Clays Clay Miner., 1992, 40, 531–539 CAS.

Footnotes

Electronic supplementary information (ESI) available. See DOI: 10.1039/c4ra08562k
Current address: Powder Technology Laboratory, Ecole Polytechnique Federale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.